MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Theta-Burst Subthalamic Nucleus Deep Brain Stimulation Enhances Segregation of Cognitive Networks in Parkinson’s Disease

    M. Abu-Zahra, S. Audrain, A. Barnett, K. Wu, W. Choi, K. Jann, C. Mark, R. Briggs, J. Cavaleri, B. Lee, X. Mason, D. Lee (Montreal, Canada)

    Objective: This study investigates the effects of a novel TBS paradigm on large-scale brain network connectivity in PD patients. Background: Parkinson’s disease (PD) is a…
  • 2025 International Congress

    The differential transcriptomic signatures of substantia nigra in Parkinson disease and Multiple system atrophy

    JH. Shin, KE. Ruhno, C. Shin, HJ. Kim, JH. Moon, HJ. Kim (Seoul, Republic of Korea)

    Objective: To investigate transcriptomic signatures of Parkinson's disease (PD) and the Parkinsonian subtype of Multiple System Atrophy (MSA-P) in the substantia nigra pars compacta (SNpc).…
  • 2025 International Congress

    Bayesian Re-Analysis of Phase I and II Subthalamic Nucleus Perfusion Changes Following Mesenchymal Stem Cell Infusion in Parkinson’s Disease

    T. Thomas, T. Ellmore, E. Tharp, J. Martinez-Lemus, C. Green, J. Suescun, C. Onuigbo, T. Le, E. Rodarte Rascon, R. Ritter Iii, M. Schiess (Houston, USA)

    Objective: To compare subthalamic nucleus (STN) perfusion changes following mesenchymal stem cell (MSC) infusion in Parkinson’s disease (PD) using Bayesian methods in both Phase I…
  • 2025 International Congress

    Impact of Patient-Specific Structural Connectivity of STN-DBS on Balance and Mobility – Pilot study

    š. Janovič, S. Holly, M. Chmelík, D. Juskanič, L. Pátrovič, A. Kušnírová, Z. Košutzká (Bratislava, Slovakia)

    Objective: To evaluate the impact of patient-specific structural connectivity between VTA in STN targeting and SMA/preSMA on functional mobility improvements in PD patients undergoing DBS.…
  • 2025 International Congress

    The Genetic Landscape of Parkinson’s Disease in African and Admixed Populations: Discovering Population-Specific Risk and Unveiling Etiological Insights

    O. Ojo, N. Okubadejo, M. Makarious, S. Bandres-Ciga (Lagos, Nigeria)

    Objective: To perform the largest PD risk genome-wide association study (GWAS) in the African and African admixed populations. Background: Investigating the genetic foundation of Parkinson’s…
  • 2025 International Congress

    First Insights into Genetic Findings from the Mexican Parkinson’s Research Network (MEX-PD): The Case of MTHFR

    P. Reyes-Pérez, A. Lazaro-Figueroa, I. Estrada-Bellmann, Y. Matuk-Pérez, C. Guerra-Galicia, K. Salinas-Barboza, E. Morelos Figaredo, N. Gandarilla-Martínez, V. Flores-Ocampo, E. Waldo, A. Zayas-Del Moral, I. Espinosa-Méndez, M. Inca-Martinez, U. Caballero-Sánchez, T. P. Leal, I. Mata, E. Gaspar-Martínez, M. Rentería, S. Alcauter-Solorzano, A. Ruiz-Contreras, A. Medina-Rivera (Queretaro, Mexico)

    Objective: To present the first genetic findings of the MEX-PD cohort, with a specific focus on analyzing the role of MTHFR variants Background: Despite significant…
  • 2025 International Congress

    A unique genetic duality: GAK and SCN4A Mutations in Myasthenic Syndrome and Early-Onset Parkinsonism in a Peruvian woman: A Case Report

    W. Trillo Alvarez, A. Carpio Peña, L. Delgado Villanueva, A. Gomez Azcue, H. Paz-Soldan Candia, M. Nieto Rosas, D. Flores Barragan, F. Arismendi Gomez (AREQUIPA, Peru)

    Objective: To present the first genetically characterized non-linear summative damage characterized case resulting in early-onset parkinsonism associated with congenital myasthenia Background: The GAK (Cyclin G…
  • 2025 International Congress

    Gene-Caffeine Interaction in Parkinson’s Disease: A Case-Control Study of Alpha-synuclein SNPs

    BG. Yan, E. Ng, Y. Zhao, EK. Tan (Singapore, Singapore)

    Objective: Investigating the interaction between genetic susceptibility and caffeine intake in modulating Parkinson’s disease (PD) risk. Background: PD arises from a complex interplay of genetic…
  • 2025 International Congress

    Oculomotor Differences in PARK2 PD: a Study of Structured and Unstructured Eye Movements in an Irish Genetic Cohort

    A. Gallagher, C. O'Keeffe, J. Inocentes, M. Bradley, E. Donlon, B. Coe, B. White, R. Walsh, T. Lynch, R. Reilly, D. Munoz, C. Fearon (Dublin, Ireland)

    Objective: To identify and measure how eye movements differ between biallelic PARK2 carriers, carriers of a single PARK2 variant and non-carriers using structured and unstructured…
  • 2025 International Congress

    Correlation between the microlesional effect of subthalamic deep brain stimulation and postoperative imaging in Parkinson’s disease

    J. Bejarano Hernandez, A. Ferreiros Celin, J. Rumià Arboix, P. Roldán Ramos, F. Valldeoriola Serra, A. Sánchez Gómez (Barcelona, Spain)

    Objective: To characterize the clinical improvement associated with MLE and its temporal progression. In addition, to analyze postoperative images and investigate whether there is a…
  • « Previous Page
  • 1
  • …
  • 78
  • 79
  • 80
  • 81
  • 82
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Comorbid Normal Pressure Hydrocephalus with Parkinson’s disease: a call for clinical awareness
  • Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley